Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF mutation testing in solid tumors: a methodological comparison.

The Journal of molecular diagnostics : JMD - 1 Sept 2014

Weyant Grace W, Wisotzkey Jeffrey D, Benko Floyd A, Donaldson Keri J

Abstract excerpt

Solid tumor genotyping has become standard of care for the characterization of proto-oncogene mutational status, which has traditionally been accomplished with Sanger sequencing. However, companion diagnostic assays and comparable laboratory-developed tests are becoming increasingly popular, such as the cobas 4800 BRAF V600 Mutation Test and the INFINITI KRAS-BRAF assay, respectively. This study evaluates and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Genetic Testing
Share to Genotyping Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins B-raf

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 25132480
DOI: 10.1016/j.jmoldx.2014.05.005

Genes

BRAF
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF mutation testing in solid tumors: a methodological comparison.PMID 25132480Read ↗

Mutations in the Serine/Threonine Kinase BRAF: Oncogenic Drivers in Solid TumorsSemantic proximity Read ↗

BRAF Mutations: Oncogenic Drivers in Solid TumorsSemantic proximity Read ↗

Resolving Discrepancies in Idylla BRAF Mutational Assay Results Using Targeted Next-Generation Sequencing.Semantic proximity Read ↗

BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.Semantic proximity Read ↗

A new generation of companion diagnostics: cobas BRAF, KRAS and EGFR mutation detection tests.Semantic proximity Read ↗

Prevalence of class I-III BRAF mutations among 114,662 cancer patients in a large genomic database.Semantic proximity Read ↗

Reliability of BRAF mutation detection using plasma sample: A systematic review and meta-analysisSemantic proximity Read ↗

Non-p.V600E BRAF Mutations Are Common Using a More Sensitive and Broad Detection ToolSemantic proximity Read ↗

BRAF V600E Mutation Across Multiple Tumor Types: Correlation Between DNA-based Sequencing and Mutation-specific ImmunohistochemistrySemantic proximity Read ↗

Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: pre-approval validation study of the companion diagnostic test for vemurafenib.Semantic proximity Read ↗

Validating a fully automated real-time PCR-based system for use in the molecular diagnostic analysis of colorectal carcinoma: a comparison with NGS and IHC.Semantic proximity Read ↗

A multiplex technology platform for the rapid analysis of clinically actionable genetic alterations and validation for BRAF p.V600E detection in 1549 cytologic and histologic specimens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.